Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms

Vickers, 2017, Implementation of dynamically updated prediction models at the point of care at a major cancer center: making nomograms more like Netflix, Urology, 102, 1, 10.1016/j.urology.2016.10.049 Moschini, 2015, Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer: impact of prostate volume on BCR, Int J Urol, 22, 555, 10.1111/iju.12748 Alberts, 2017, Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer, BJU Int, 120, 511, 10.1111/bju.13836 Lin, 2020, 17-Gene genomic prostate score test results in the Canary Prostate Active Surveillance Study (PASS) cohort, J Clin Oncol, 38, 1549, 10.1200/JCO.19.02267 Freedland, 2002, Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score, J Urol, 168, 110, 10.1016/S0022-5347(05)64841-0 Magheli, 2008, Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy, J Urol, 179, 1780, 10.1016/j.juro.2008.01.032 Freedland, 2003, Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base, J Urol, 169, 969, 10.1097/01.ju.0000051400.85694.bb Ito, 2019, Clinical usefulness of prostate and tumor volume related parameters following radical prostatectomy for localized prostate cancer, J Urol, 201, 535, 10.1016/j.juro.2018.09.060